文献速递乳腺技术与安全US

基于纵向双模态超声的Delta影像组学可早期预测乳腺癌患者新辅助化疗反应

Delta Radiomics Based on Longitudinal Dual-modal Ultrasound Can Early Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
PubMed 文献 · Acad Radiol · 2023-12-05

前瞻性纳入2016年9月至2022年3月接受新辅助化疗的112例乳腺癌患者,于治疗前及第2、4周期后采集B型超声和剪切波弹性成像数据并提取影像组学特征,构建Delta影像组学模型。纵向双模态超声影像组学模型预测病理反应的AUC、敏感度和特异度分别为0.97、95.52%和91.11%,剪切波弹性成像Delta特征预测效能显著优于B型超声。

要点

  • 纵向双模态超声影像组学模型预测新辅助化疗病理反应AUC达0.97。
  • 剪切波弹性成像Delta特征预测效能显著优于B型超声(Delong检验P<0.01)。
  • 第2周期与第4周期的Delta影像组学特征预测效能无显著差异。

核心结论

  • 纵向双模态超声影像组学模型在新辅助化疗早期预测乳腺癌病理反应方面表现优异。

研究设计与样本

  • 前瞻性研究纳入2016年9月至2022年3月接受新辅助化疗的112例乳腺癌患者,于治疗前及第2、4周期后采集B型超声和剪切波弹性成像数据,提取影像组学特征并使用支持向量机分类器建立Delta影像组学特征。

诊断标准与关键数值

  • Delta B型超声特征第2周期和第4周期预测新辅助化疗反应的AUC分别为0.83和0.84,Delta剪切波弹性成像特征第2周期和第4周期AUC分别为0.88和0.90,剪切波弹性成像Delta特征预测效能显著优于B型超声(Delong检验P<0.01),B型超声或剪切波弹性成像数据中第2周期与第4周期Delta特征效能无显著差异;纵向双模态超声影像组学模型AUC为0.97,敏感度95.52%,特异度91.11%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop a monitoring model using radiomics analysis based on longitudinal B-mode ultrasound (BUS) and shear wave elastography (SWE) to early predict pathological response to neoadjuvant chemotherapy (NAC) in breast cancer patients.

MATERIALS AND METHODS: In this prospective study, 112 breast cancer patients who received NAC between September 2016 and March 2022 were included. The BUS and SWE data of breast cancer were obtained prior to treatment as well as after two and four cycles of NAC. Radiomics features were extracted followed by measuring the changes in radiomics features compared to baseline after the second and fourth cycles of NAC (△R [C2], △R [C4]), respectively. The delta radiomics signatures were established using a support vector machine classifier.

RESULTS: The area under receiver operating characteristic curve (AUC) values of △RBUS (C2) and △RBUS (C4) for predicting the response to NAC were 0.83 and 0.84, while those of △RSWE (C2) and △RSWE (C4) were 0.88 and 0.90, respectively. △RSWE exhibited significantly superior performance to △RBUS for predicting NAC response (Delong test, p < 0.01). No significant differences were observed in the performances between △R (C2) and △R (C4) based on BUS or SWE data. The longitudinal dual-modal ultrasound radiomics (LDUR) model had an excellent discrimination, good calibration and clinical usefulness, with the AUC, sensitivity and specificity of 0.97, 95.52% and 91.11%, respectively.

CONCLUSION: The LDUR model achieved excellent performance in predicting the pathological response to chemotherapy during the early stages of NAC for breast cancer.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Huang JX, Wu L, Wang XY, et al. Delta Radiomics Based on Longitudinal Dual-modal Ultrasound Can Early Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. Acad Radiol. 2023. PMID: 38057180. doi:10.1016/j.acra.2023.10.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。